TickerFactsScreenerDevelopers

VYNE Therapeutics Inc. (VYNE) — Operating Income

Annual figures by fiscal year, from SEC filings.

2015: -$4.61M2016: -$14.33M2017: -$29.59M2018: -$74.89M2019: -$95.87M2020: -$252.55M2021: -$38.91M2022: -$34.30M2023: -$29.26M2024: -$43.64M2025: -$29.75M-$29.75M
2015Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$29.75M+31.8%
2024-$43.64M-49.1%
2023-$29.26M+14.7%
2022-$34.30M+11.9%
2021-$38.91M+84.6%
2020-$252.55M-163.4%
2019-$95.87M-28.0%
2018-$74.89M-153.1%
2017-$29.59M-106.5%
2016-$14.33M-211.0%
2015-$4.61M—